BioCentury
ARTICLE | Financial News

Apricus completes follow-on

April 21, 2017 7:58 PM UTC

On April 21, urology and rheumatology company Apricus Biosciences Inc. (NASDAQ:APRI) raised $7 million through the sale of 5 million units at $1.40 in a follow-on underwritten by H.C. Wainwright. Eac...

BCIQ Company Profiles

Apricus Biosciences Inc.